RD
Raymond Dwek (Director) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in United Therapeutics Corporation (UTHR). The largest single filing was $1.1M of UTHR (4,000 sh × $284.55, as filed), executed Apr 7 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.9M
shares × price, as filed
Last traded
Apr 21 2025
Filed Apr 22 2025
Median ADV $265.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 24 months
Most traded names
UTHRRecent filings
UTHRSALE
United Therapeutics Corporation
View filing →
$857K3,000 sh × $285.57
Exec Apr 21 2025
Filed Apr 22 2025 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $855K
3,000 sh × $285.16
Exec Apr 14 2025
Filed Apr 15 2025 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $1.1M
4,000 sh × $284.55
Exec Apr 7 2025
Filed Apr 8 2025 · 5:30 PM ET